Publications
- Current recommendations in chelation therapy2013 | First Faculty of Medicine
- Treatment of patients with myelodysplastic syndrome with iron overload oral chelator deferasirox2013 | First Faculty of Medicine
- Deferasirox in patients with myelodysplastic syndrome and iron overload - Results of the EPIC study - Commenting on the study2013 | First Faculty of Medicine
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publication without faculty affiliation
- Iron overload in patients receiving frequent blood transfusions and its therapy2012 | First Faculty of Medicine
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Commentary on a study2011 | Publication without faculty affiliation
- Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice2010 | First Faculty of Medicine
- Experiences with chelation therapy in myelodysplastic syndrome.2009 | Publication without faculty affiliation
- Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms2024 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Science
Loading network view...